影像学侵袭性小肺癌:肺段切除与肺叶切除的预后比较
该回顾性多中心研究纳入1046例临床IA1-IA2期肺癌患者,定义影像学侵袭性小肺癌为实性成分占比≥0.8或最大标准化摄取值≥2.5。在522例侵袭性小肺癌中,经倾向性评分匹配比较肺段切除与肺叶切除的预后,未发现5年无复发生存和总生存的显著差异。
要点
- 影像学侵袭性小肺癌定义为实性成分占比≥0.8或最大标准化摄取值≥2.5。
- 在侵袭性小肺癌中,肺段切除与肺叶切除的5年生存无显著差异。
- 实性成分占比和最大标准化摄取值升高与更差的无复发生存独立相关。
核心结论
- 在具有高复发风险的影像学侵袭性小肺癌患者中,肺段切除与肺叶切除之间未发现生存差异。
研究设计与样本
- 回顾性多中心研究,纳入1046例临床IA1-IA2期肺癌患者,其中522例为影像学侵袭性小肺癌,采用倾向性评分匹配比较肺段切除与肺叶切除的预后。
主要发现
- 多因素分析显示,术前高分辨率CT实性成分占比升高(P = 0.037)和18F-FDG PET/CT最大标准化摄取值升高(P = 0.029)与更差的无复发生存独立相关。
- 在侵袭性小肺癌患者中,肺叶切除(n = 392)与肺段切除(n = 130)的5年无复发生存率(81% vs 90%;P = 0.33)和总生存率(88% vs 93%;P = 0.76)无显著统计学差异。
- 在115对倾向性匹配患者中,肺叶切除与肺段切除的5年无复发生存率(83.3% vs 90.9%)和总生存率(88.3% vs 94.5%)相似。
关键数值与推荐
- 影像学侵袭性小肺癌定义为实性肿瘤≤2 cm且实性成分占比≥0.8或最大标准化摄取值≥2.5。
临床怎么用
- 对于影像学侵袭性小肺癌(实性成分占比≥0.8或最大标准化摄取值≥2.5),肺段切除可作为与肺叶切除相当的选项,但需结合患者具体情况个体化决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The purpose of this study was to determine the radiological characteristics of aggressive small-sized lung cancer and to compare the outcomes between segmentectomy and lobectomy in patients with these lung cancers. METHODS: A series of 1046 patients with clinical stage IA1-IA2 lung cancer who underwent lobectomy or segmentectomy at 3 institutions was retrospectively evaluated to identify radiologically aggressive small-sized (solid tumour size ≤ 2 cm) lung cancers. Prognosis of segmentectomy was compared with that of lobectomy in 522 patients with radiologically aggressive small-sized lung cancer using propensity score matching. RESULTS: Multivariable analysis showed that increasing consolidation-to-tumour ratio on preoperative high-resolution computed tomography (CT) (P = 0.037) and maximum standardized uptake on 18 fluoro-2-deoxyglucose positron emission tomography/CT (P = 0.029) was independently associated with worse recurrence-free survival. Based on analysis of the receiver operating characteristic curve, radiologically aggressive lung cancer was defined as a radiologically solid (consolidation-to-tumour ratio ≥ 0.8) or highly metabolic (maximum standardized uptake ≥ 2.5) tumour. Among patients with radiologically aggressive lung cancer, no significant statistical differences in 5-year recurrence-free (81% vs 90%; P = 0.33) and overall (88% vs 93%; P = 0.76) survival comparing lobectomy (n = 392) to segmentectomy (n = 130) were observed. Among 115 propensity-matched pairs, 5-year recurrence-free survival and overall survival were similar between patients who underwent lobectomy and those who underwent segmentectomy (83.3% and 88.3% vs 90.9% and 94.5%, respectively). CONCLUSIONS: Difference in survival was not identified with segmentectomy and lobectomy in patients with radiologically aggressive small-sized lung cancer with high risk of recurrence.
引用
- Kamigaichi A, Tsutani Y, Mimae T, et al. Prognosis of segmentectomy and lobectomy for radiologically aggressive small-sized lung cancer. Eur J Cardiothorac Surg. 2020. PMID: 32893296. doi:10.1093/ejcts/ezaa231
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。